Kintara Therapeutics News

8-K: Current report

Apr 25 21:09

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 25 21:09

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 3 19:17

Kintara Therapeutics | 8-K: Current report

Apr 3 19:12

Kintara Therapeutics | RW: Registration Withdrawal Request

Mar 13 19:03

Kintara Therapeutics | 8-K: Current report

Feb 27 20:05

Kintara Therapeutics | 8-K: Current report

Feb 26 20:05

Kintara Therapeutics | 8-K: Current report

Feb 22 20:01

Kintara Therapeutics | 8-K: Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update

Feb 15 06:57

Kintara Therapeutics | 10-Q: Quarterly report

Feb 15 05:15

Kintara Therapeutics | 8-K: Current report

Feb 12 22:09

Kintara Therapeutics | 8-K: Current report

Dec 19, 2023 05:10

Kintara Therapeutics | 424B5: Prospectus

Dec 19, 2023 05:05

Kintara Therapeutics | 8-K: Current report

Dec 16, 2023 05:15

Kintara Therapeutics | 8-K: Current report

Dec 7, 2023 22:10

Kintara Therapeutics | 8-K: Current report

Dec 5, 2023 22:10

Kintara Therapeutics | 8-K: Current report

Nov 21, 2023 20:55

Kintara Therapeutics | 8-K: Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update

Nov 14, 2023 05:15

Kintara Therapeutics: Q1 2024 Earnings Report

Nov 14, 2023 05:05

Kintara Therapeutics | 8-K: Current report

Oct 31, 2023 20:10